China SXT Pharmaceuticals, Inc. (SXTC)
NASDAQ: SXTC · IEX Real-Time Price · USD
0.187
-0.005 (-2.71%)
At close: Jan 21, 2022 4:00 PM
0.195
0.008 (4.234%)
After-hours:Jan 21, 2022 7:59 PM EST
Income Statement (Annual)
Millions USD. Fiscal year is Apr - Mar.
| Year | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|
| Revenue | 0.88 | 0.33 | 0.21 | 1.32 | 0.73 |
| Revenue Growth (YoY) | 167.83% | 55.75% | -83.89% | 80.04% | - |
| Cost of Revenue | -1.94 | -2.46 | -2.4 | -3.62 | -2.57 |
| Gross Profit | 2.82 | 2.79 | 2.61 | 4.93 | 3.3 |
| Selling, General & Admin | 5.04 | 4.04 | 2.84 | 1.77 | 0.71 |
| Operating Expenses | 5.04 | 4.04 | 2.84 | 1.77 | 0.71 |
| Operating Income | -2.21 | -1.26 | -0.23 | 3.17 | 2.59 |
| Interest Expense / Income | 1.62 | 3.35 | 0.01 | 0 | 0.04 |
| Other Expense / Income | -0.89 | 5.78 | -2.03 | 1.54 | 0.97 |
| Pretax Income | -2.94 | -10.39 | 1.79 | 1.63 | 1.58 |
| Income Tax | -0.19 | -0.1 | 0.25 | 0.44 | 0.4 |
| Net Income | -2.75 | -10.29 | 1.54 | 1.19 | 1.19 |
| Net Income Common | -2.75 | -10.29 | 1.54 | 1.19 | 1.19 |
| Net Income Growth | - | - | 29.61% | 0.21% | - |
| Shares Outstanding (Basic) | 14 | 6 | 5 | 5 | 5 |
| Shares Outstanding (Diluted) | 14 | 6 | 5 | 5 | 5 |
| Shares Change | 132.78% | 20.23% | 2.84% | 0.00% | - |
| EPS (Basic) | -0.19 | -1.66 | 0.30 | 0.24 | 0.24 |
| EPS (Diluted) | -0.19 | -1.66 | 0.30 | 0.24 | 0.24 |
| EPS Growth | - | - | 26.69% | 0.00% | - |
| Free Cash Flow Per Share | -0.10 | 0.09 | -0.07 | 0.18 | 0.02 |
| Gross Margin | 318.99% | 844.05% | 1231.48% | 374.69% | 451.26% |
| Operating Margin | -250.13% | -380.06% | -108.13% | 240.35% | 354.23% |
| Profit Margin | -310.53% | -3113.48% | 725.52% | 90.17% | 162.01% |
| Free Cash Flow Margin | -159.28% | 159.67% | -169.51% | 67.61% | 15.57% |
| Effective Tax Rate | 6.55% | 0.98% | 14.08% | 27.04% | 25.00% |
| EBITDA | -0.98 | -6.71 | 1.98 | 1.76 | 1.72 |
| EBITDA Margin | -110.74% | -2030.37% | 932.13% | 133.47% | 235.11% |
| EBIT | -1.33 | -7.04 | 1.8 | 1.63 | 1.62 |
| EBIT Margin | -149.77% | -2130.80% | 846.85% | 123.65% | 221.54% |
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).